LTIP912A - Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them - Google Patents

Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them

Info

Publication number
LTIP912A
LTIP912A LTIP912A LTIP912A LTIP912A LT IP912 A LTIP912 A LT IP912A LT IP912 A LTIP912 A LT IP912A LT IP912 A LTIP912 A LT IP912A LT IP912 A LTIP912 A LT IP912A
Authority
LT
Lithuania
Prior art keywords
lower alkyl
hydrogen
group
cor
alkyl group
Prior art date
Application number
LTIP912A
Inventor
Malcolm Sainsbury
Howard G Shertzer
Original Assignee
Univ Bath
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bath, Univ Cincinnati filed Critical Univ Bath
Publication of LTIP912A publication Critical patent/LTIP912A/en
Publication of LT3675B publication Critical patent/LT3675B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Compounds of the formula <CHEM> wherein R is hydrogen or a lower alkyl group or COR<1><5> R<1>, R<2>, R<1><1> and R<1><2>, are hydrogen or a lower alkyl group, R<3>, R<4>, R<5> and R<6> are hydrogen, hydroxy, halogen, a lower alkyl group, a lower alkoxy group or a mono- or di-lower alkyl amino group, NH2 or NR<1><3>COR<1><4>, R<7>, R<8>, R<9> and R<1><0> are hydrogen, hydroxy, a lower alkyl group, a lower alkoxy group, a mono- or di-lower alkylamino group, or NH<1><3>COR<1><4> wherein R<1><3>, R<1><4> and R<1><5> are hydrogen or a lower alkyl group, enantiomers and salts thereof, with the proviso that when R is COR<1><5> then at least one of R<3> to R<1><0> are hydroxy or a mono or di-lower alkylamino group, are useful as antioxidants, within the medical and non-medical field. Many of the compounds of formula IA and IB are new and various methods for preparing them are described.
LTIP912A 1989-06-22 1993-08-30 Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them LT3675B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902274A SE8902274D0 (en) 1989-06-22 1989-06-22 INDENOIDOLE COMPOUNDS II

Publications (2)

Publication Number Publication Date
LTIP912A true LTIP912A (en) 1995-03-27
LT3675B LT3675B (en) 1996-01-25

Family

ID=20376370

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP912A LT3675B (en) 1989-06-22 1993-08-30 Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them

Country Status (34)

Country Link
EP (1) EP0409410B1 (en)
JP (1) JP3064411B2 (en)
KR (1) KR920702679A (en)
CN (1) CN1033029C (en)
AT (1) ATE135688T1 (en)
BG (1) BG60317B2 (en)
CA (1) CA2060897A1 (en)
DD (1) DD297960A5 (en)
DE (1) DE69025998T2 (en)
DK (1) DK0409410T3 (en)
DZ (1) DZ1428A1 (en)
ES (1) ES2084660T3 (en)
FI (1) FI100800B (en)
GR (1) GR3019779T3 (en)
HR (1) HRP920903B1 (en)
HU (1) HUT59097A (en)
IE (1) IE74682B1 (en)
IL (1) IL94830A (en)
IS (1) IS3590A7 (en)
LT (1) LT3675B (en)
LV (1) LV10253B (en)
MX (1) MX21244A (en)
MY (1) MY107311A (en)
NO (1) NO177932C (en)
NZ (1) NZ234175A (en)
PL (1) PL167761B1 (en)
PT (1) PT94468B (en)
RO (1) RO111573B1 (en)
RU (1) RU2104270C1 (en)
SE (1) SE8902274D0 (en)
SI (1) SI9011223B (en)
WO (1) WO1990015799A1 (en)
YU (1) YU122390A (en)
ZA (1) ZA904827B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99232A (en) * 1990-10-16 1992-09-30 Univ Bath PROCESS FOR THE PREPARATION OF INDOOR-INDOLE COMPOUNDS OF PHARMACEUTICAL COMPOSITIONS, AND OF STABILIZATION OF SUSCEPTIVE COMPOUNDS OF OXIDIZING DETERIORATION
JPH0656669A (en) * 1992-06-11 1994-03-01 Asahi Breweries Ltd Pterine derivative preparation having active oxygen-scavenging action
SE9302431D0 (en) * 1993-07-16 1993-07-16 Ab Astra USE OF INDENOINDOLE COMPOUNDS
AU675141B2 (en) * 1993-07-20 1997-01-23 Adir Et Compagnie (Thia)cycloalkyl(b)indoles, process for preparing them and pharmaceutical compositions containing them
EP1135393A2 (en) * 1998-12-04 2001-09-26 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
US6288099B1 (en) 1998-12-04 2001-09-11 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
FR2826009B1 (en) * 2001-06-13 2003-08-15 Servier Lab NOVEL INDENOINDOLON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX2008000462A (en) 2005-07-14 2008-03-10 Irm Llc Heterotetracyclic compounds as tpo mimetics.
DE102006047231B4 (en) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituted indeno [1,2-b] indole derivatives as novel inhibitors of the protein kinase CK2 and their use as tumor therapeutics, cytostatic agents and diagnostics
CA3124852A1 (en) 2011-06-16 2012-12-20 Korea Research Institute Of Chemical Technology Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
WO2014092514A1 (en) 2012-12-14 2014-06-19 한국화학연구원 Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient

Also Published As

Publication number Publication date
GR3019779T3 (en) 1996-07-31
EP0409410A1 (en) 1991-01-23
IL94830A0 (en) 1991-04-15
IS3590A7 (en) 1990-12-23
LV10253B (en) 1995-04-20
SE8902274D0 (en) 1989-06-22
AU644084B2 (en) 1993-12-02
ATE135688T1 (en) 1996-04-15
HRP920903B1 (en) 1998-06-30
MX21244A (en) 1994-03-31
PT94468B (en) 1997-12-31
ES2084660T3 (en) 1996-05-16
HRP920903A2 (en) 1994-04-30
HU904825D0 (en) 1992-03-30
PL167761B1 (en) 1995-10-31
WO1990015799A1 (en) 1990-12-27
MY107311A (en) 1995-11-30
NO177932B (en) 1995-09-11
YU122390A (en) 1992-09-07
CA2060897A1 (en) 1990-12-23
RO111573B1 (en) 1996-11-29
HUT59097A (en) 1992-04-28
FI915999A0 (en) 1991-12-19
SI9011223A (en) 1997-10-31
DK0409410T3 (en) 1996-04-29
KR920702679A (en) 1992-10-06
JP3064411B2 (en) 2000-07-12
AU5836990A (en) 1991-01-08
DE69025998T2 (en) 1996-08-08
SI9011223B (en) 1998-08-31
DD297960A5 (en) 1992-01-30
NZ234175A (en) 1992-12-23
IE902247A1 (en) 1991-01-16
RU2104270C1 (en) 1998-02-10
IE902247L (en) 1990-12-22
FI100800B (en) 1998-02-27
NO915049D0 (en) 1991-12-20
CN1051554A (en) 1991-05-22
NO177932C (en) 1995-12-20
DE69025998D1 (en) 1996-04-25
LV10253A (en) 1994-10-20
PT94468A (en) 1991-02-08
NO915049L (en) 1992-02-21
EP0409410B1 (en) 1996-03-20
BG60317B2 (en) 1994-07-25
ZA904827B (en) 1991-04-24
JPH04505923A (en) 1992-10-15
DZ1428A1 (en) 2004-09-13
CN1033029C (en) 1996-10-16
PL285752A1 (en) 1991-03-11
IL94830A (en) 1996-07-23
IE74682B1 (en) 1997-07-30
LT3675B (en) 1996-01-25

Similar Documents

Publication Publication Date Title
FI893467A (en) Process for the preparation of 4-oxoquinoline-3-carboxylic acid derivatives useful as a medicament
LTIP912A (en) Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them
IL75115A (en) 3-oxadiazolyl-beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ES8307824A1 (en) New cephem compounds and processes for preparation thereof.
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
EP0161575A3 (en) B-carboline-3-carboxylic acid derivatives, method of preparing the same and their use
SE8902273D0 (en) INDENOINDOLE COMPOUNDS I
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
JO1676B1 (en) Further indenoindoles compounds ii
HUT44268A (en) Process for preparing compounds with construction similar to antibiotic tan-749
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
ES8401952A1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof.
HUT47897A (en) Process for producing salicilates and pharmaceutical compositions containing them
IL86136A0 (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same
LTIP1788A (en) Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in medicine
GR852126B (en)

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19980830